Surgical therapy for metastatic disease to the liver

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 139-156

  Bentrem, David J ^a   DeMatteo, Ronald P ^a   Blumgart, Leslie H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Colorectal cancer; Colorectal metastases; Hepatic resection; Metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL EXAMINATION; COLORECTAL CANCER; HUMAN; LIVER METASTASIS; MULTIMODALITY CANCER THERAPY; PARTIAL HEPATECTOMY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT INDICATION;

CARCINOMA, NEUROENDOCRINE; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; SURVIVAL RATE; UROGENITAL NEOPLASMS;

EID: 14544282509     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.082103.104630     Document Type: Review

References (110)

1. Smith A, DeMatteo R, Fong Y, Blumgart L. 2001. Metastatic liver cancer. In Atlas of Hepatobiliary Cancer, ed. L Blumgart, Y Fong, W Jarnagin, pp. 75-95. London: Decker
2. McCarter MD, Fong Y. 2000. Metastatic liver tumors. Semin. Surg. Oncol. 19:177-88
3. DeMatteo RP, Fong Y, Jarnagin WR, et al. 2000. Recent advances in hepatic resection. Semin. Surg. Oncol. 19:200-7
4. Melendez JA, Arslan V, Fischer ME, et al. 1998. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of post-operative renal dysfunction. J. Am. Coll. Surg. 187:620-25
5. DeMatteo RP, Palese C, Jarnagin WR, et al. 2000. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J. Gastrointest. Surg. 4:178-84
6. Jarnagin WR, Gonen M, Fong Y, et al. 2002. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann. Surg. 236:397-406
7. Choti MA, Bowman HM, Pitt HA, et al. 1998. Should hepatic resections be performed at high-volume referral centers? J. Gastrointest. Surg. 2:11-20
8. Fong Y, Blumgart LH. 1998. Hepatic colorectal metastasis: current status of surgical therapy. Oncology (Huntington) 12:1489-98
9. Weber SM, Jarnagin WR, DeMatteo RP, et al. 2000. Survival after resection of multiple hepatic colorectal metastases. Ann. Surg. Oncol. 7:643-50
10. Jemal A, Tiwari RC, Murray T, et al. 2004. Cancer statistics, 2004. CA Cancer J. Clin. 54:8-29
11. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. 1991. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29
12. Bengmark S, Hafstrom L. 1969. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonie and rectal carcinoma by laparotomy. Cancer 23:198-202
13. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. 1981. Natural history of patients with untreated liver metastases from colorectal cancer. Am. J. Surg. 141:586-89
14. Jaffe BM, Donegan WL, Watson F, et al. 1968. Factors influencing survival in patients with untreated hepatic metastases. Surg. Gynecol. Obstet. 127:1-11
15. Goslin R, Steele G Jr, Zamcheck N, et al. 1982. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis. Colon Rectum 25:749-54
16. de Brauw LM, van de Velde CJ, Bouwhuis-Hoogerwerf ML, et al. 1987. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. J. Surg. Oncol 34:81-86
17. Wilson SM, Adson MA. 1976. Surgical treatment of hepatic metastases from colorectal cancers. Arch. Surg. 111:330-34
18. Wagner JS, Adson MA, Van Heerden JA, et al. 1984. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann. Surg. 199:502-8
19. Buroker TR, O'Connell MJ, Wieand HS, et al. 1994. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J. Clin. Oncol. 12:14-20
20. Leichman CG, Fleming TR, Muggia FM, et al. 1995. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J. Clin. Oncol. 13:1303-11
21. Colucci G, Maiello E, Leo S, et al. 1994. Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM). Anticancer Res. 14:2157-62
22. Saltz LB, Cox JV, Blanke C, et al. 2000. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med. 343:905-14
23. Advanced Colorectal Cancer MetaAnalysis Project. 1992. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J. Clin. Oncol. 10:896-903
24. de Gramont A, Bosset JF, Milan C, et al. 1997. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J. Clin. Oncol. 15:808-15
25. Schmoll H, Kohne C, Lorenz M, et al. 2000. Weekly 24 h infusion of high-dose 5-fluorouracil with or without folinic acid vs. bolus 5-FU/FA in advanced colorectal cancer: a randomized phase III study of the EORTC GITCCG and the AIO. Proc. Am. Soc. Clin. Oncol. 19:241a (Abstr.)
26. Van Cutsem E, Twelves C, Cassidy J, et al. 2001. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J. Clin. Oncol. 19:4097-106
27. Hoff PM, Ansari R, Batist G, et al. 2001. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J. Clin. Oncol. 19:2282-92
28. Rothenberg ML, Oza AM, Bigelow RH, et al. 2003. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J. Clin. Oncol. 21:2059-69
29. de Gramont A, Figer A, Seymour M, et al. 2000. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18:2938-47
30. Goldberg RM, Sargent DJ, Morton RF, et al. 2004. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J. Clin. Oncol. 22:23-30
31. Hurwitz HI, Fehrenbacher L, Cartwright T, et al. 2003. Bevacizumab prolongs survival in first-line colorectal cancer: results of a phase III trial of bevacizumab in combination with bolus IFL as first-line therapy in subjects with metastatic CRC. Proc. Am. Soc. Clin. Oncol. 22:906
32. Saltz LB, Rubin M, et al. 2001. Cetuximab plus irinotecan is active in CPT-11 refractory colorectal cancer that expresses epidermal growth factor receptor. Proc. Am. Soc. Clin. Oncol. 21:3a(Abstr.)
33. Schoffski P, Lutz M, Folprecht G, et al. 2002. Cetuximab plus irinotecan plus infusional 5-FU-folinic acid is safe and active in metastatic colorectal cancer that expresses epidermal growth factor receptor. Proc. Am. Soc. Clin. Oncol. 21:135a (Abstr.)
34. Vassiliades VG, Foley WD, Alarcon J, et al. 1991. Hepatic metastases: CT versus MR imaging at 1.5T. Gastrointest. Radiol. 16:159-63
35. Povoski SP, Fong Y, Sgouros SC, et al. 1998. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann. Surg. Oncol. 5:9-15
36. Kronawitter U, Kemeny NE, Heelan R, et al. 1999. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 86:229-35
37. Smith JW, Fortner JG, Burt M. 1992. Resection of hepatic and pulmonary metastases from colorectal cancer. Surg. Oncol. 1:399-404
38. DeMatteo R, Minnard E, Kemeny N, et al. 1999. Outcome after resection of both liver and lung metastases in patients with colorectal cancer. Proc. Am. Soc. Clin. Oncol. 18:958
39. Findlay M, Young H, Cunningham D, et al. 1996. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J. Clin. Oncol. 14:700-8
40. Beets G, Penninckx F, Schiepers C, et al. 1994. Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Br. J. Surg. 81:1666-70
41. Fong Y, Saldinger PF, Akhurst T, et al. 1999. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am. J. Surg. 178:282-87
42. Castaing D, Emond J, Kunstlinger F, et al. 1986. Utility of operative ultrasound in the surgical management of liver tumors. Ann. Surg. 204:600-5
43. Potter MW, Shah SA, McEnaney P, et al. 2000. A critical appraisal of laparoscopic staging in hepatobiliary and pancreatic malignancy. Surg. Oncol. 9:103-10
44. Castaing D, Kunstlinger F, Habib N, et al. 1985. Intraoperative ultrasonographic study of the liver. Methods and anatomic results. Am. J. Surg. 149:676-82
45. Kemeny N, Huang Y, Cohen AM, et al. 1999. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 341:2039-48
46. Scheele J, Stang R, Altendorf-Hofmann A, et al. 1995. Resection of colorectal liver metastases. World J. Surg. 19:59-71
47. Fong Y, Fortner J, Sun RL, et al. 1999. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230:309-18
48. Scheele J, Stangl R, Altendorf-Hofmann A. 1990. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 77:1241-46
49. Nordlinger B, Quilichini MA, Pare R, et al. 1987. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann. Surg. 205:256-63
50. D'Angelica M, Brennan MF, Fortner JG, et al. 1997. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J. Am. Coll. Surg. 185:554-59
51. Fong Y, Cohen AM, Fortner JG, et al. 1997. Liver resection for colorectal metastases. J. Clin. Oncol. 15:938-46
52. Nadig DE, Wade TP, Fairchild RB, et al. 1997. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch. Surg. 132:115-19
53. Tuttle TM, Curley SA, Roh MS. 1997. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann. Surg. Oncol. 4:125-30
54. Blumgart LH, Allison DJ. 1982. Resection and embolization in the management of secondary hepatic tumors. World J. Surg. 6:32-45
55. Cady B, Monson DO, Swinton NW. 1970. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg. Gynecol Obstet. 131:697-700
56. Martin R, Paty P, Fong Y, et al. 2003. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J. Am. Coll. Surg. 197:233-41
57. Hughes KS, Simon R, Songhorabodi S, et al. 1986. Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 100:278-84
58. Rosen CB, Nagorney DM, Taswell HF, et al. 1992. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg. 216:493-504
59. Ekberg H, Tranberg KG, Andersson R, et al. 1987. Pattern of recurrence in liver resection for colorectal secondaries. World J. Surg. 11:541-47
60. Fortner JG, Silva JS, Golbey RB, et al. 1984. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann. Surg. 199:306-16
61. Doci R, Gennari L, Bignami P, et al. 1991. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br. J. Surg. 78:797-801
62. Hughes KS, Rosenstein RB, Songhorabodi S, et al. 1988. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis. Colon Rectum 31:1-4
63. Fong Y, Blumgart LH, Cohen A, et al. 1994. Repeat hepatic resections for metastatic colorectal cancer. Ann. Surg. 220:657-62
64. Petrowsky H, Gonen M, Jarnagin W, et al. 2002. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann. Surg. 235:863-71
65. Bonetti A. 2003. Hepatic artery infusion for liver metastases from colorectal cancer. Lancet 361:358-59
66. Kemeny N, Seiter K, Niedzwiecki D, et al. 1992. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69:327-34
67. Rougier P, Laplanche A, Huguier M, et al. 1992. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J. Clin. Oncol 10:1112-18
68. Meta-Analysis Group in Cancer. 1996. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst. 88:252-58
69. Kemeny MM, Adak S, Gray B, et al. 2002. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J. Clin. Oncol. 20:1499-505
70. Sadahiro S, Suzuki T, Ishikawa K, et al. 2004. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Cancer 100:590-97
71. Adam R, Avisar E, Ariche A, et al. 2001. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann. Surg. Oncol. 8:347-53
72. Adam R, Huguet E, Azoulay D, et al. 2003. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg. Oncol. Clin. N. Am. 12:211-20, xii
73. Curley SA, Izzo F, Delrio P, et al. 1999. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann. Surg. 230:1-8
74. Pawlik TM, Izzo F, Cohen DS, et al. 2003. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann. Surg. Oncol. 10:1059-69
75. Tanabe KK, Curley SA, Dodd GD, et al. 2004. Radiofrequency ablation: the experts weigh in. Cancer 100:641-50
76. Bilchik AJ, Wood TF, Allegra D, et al. 2000. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch. Surg. 135:657-62
77. Bleicher RJ, Allegra DP, Nora DT, et al. 2003. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann. Surg. Oncol. 10:52-58
78. Hise I, Persson B, Tibblin S. 1995. Neuroendocrine metastases of the liver. World J. Surg. 19:76-82
79. Que FG, Nagorney DM, Batts KP, et al. 1995. Hepatic resection for metastatic neuroendocrine carcinomas. Am. J. Surg. 169:36-42
80. Sarmiento JM, Heywood G, Rubin J, et al. 2003. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J. Am. Coll. Surg. 197:29-37
81. McEntee GP, Nagorney DM, Kvols LK, et al. 1990. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 108:1091-96
82. Yao KA, Talamonti MS, Nemcek A, et al. 2001. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130:677-82
83. Harrison LE, Brennan MF, Newman E, et al. 1997. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121:625-32
84. Foster JH. 1978. Survival after liver resection for secondary tumors. Am. J. Surg. 135:389-94
85. Elias D, Cavalcanti de Albuquerque A, et al. 1998. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J. Am. Coll. Surg. 187:487-93
86. Miyazaki M, Itoh H, Nakagawa K, et al. 1997. Hepatic resection of liver metastases from gastric carcinoma. Am. J. Gastroenterol 92:490-93
87. Bines SD, England G, Deziel DJ, et al. 1993. Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery 114:799-805
88. Ambiru S, Miyazaki M, Ito H, et al. 2001. Benefits and limits of hepatic resection for gastric metastases. Am. J. Surg. 181:279-83
89. DeMatteo RP, Shah A, Fong Y, et al. 2001. Results of hepatic resection for sarcoma metastatic to liver. Ann. Surg. 234:540-47
90. Elias D, Lasser PH, Montrucolli D, et al. 1995. Hepatectomy for liver metastases from breast cancer. Eur. J. Surg. Oncol. 21:510-13
91. Salmon RJ, Levy C, Plancher C, et al. 1998. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur. J. Surg. Oncol. 24:127-30
92. Adson MA, van Heerden JA, Adson MH, et al. 1984. Resection of hepatic metastases from colorectal cancer. Arch. Surg. 119:647-51
93. Schlag P, Hohenberger P, Herfarth C. 1990. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur. J. Surg. Oncol. 16:360-65
94. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. 1994. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703-10
95. Jamison RL, Donohue JH, Nagorney DM, et al. 1997. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch. Surg. 132:505-0
96. Choti MA, Sitzmann JV, Tiburi MF, et al. 2002. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg. 235:759-66
97. Pestana C, Reitemeier RJ, Moertel CG, et al. 1964. The natural history of carcinoma of the colon and rectum. Am. J. Surg. 108:826-29
98. Lahr CJ, Soong SJ, Cloud G, et al. 1983. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J. Clin. Oncol. 1:720-26
99. Wood CB, Gillis CR, Blumgart LH. 1976. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin. Oncol. 2:285-88
100. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. 1994. Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-10
101. Rougier P, Milan C, Lazorthes F, et al. 1995. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancerologie Digestive. Br. J. Surg. 82:1397-400
102. Stone MD, Cady B, Jenkins RL, et al. 1990. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch. Surg. 125:718-21
103. Bozzetti F, Bignami P, Montalto F, et al. 1992. Repeated hepatic resection for recurrent metastases from colorectal cancer. Br. J. Surg. 79:146-48
104. Vaillant JC, Balladur P, Nordlinger B, et al. 1993. Repeat liver resection for recurrent colorectal metastases. Br. J. Surg. 80:340-44
105. Elias D, Lasser P, Hoang JM, et al. 1993. Repeat hepatectomy for cancer. Br. J. Surg. 80:1557-62
106. Que FG, Nagorney DM. 1994. Resection of 'recurrent' colorectal metastases to the liver. Br. J. Surg. 81:255-58
107. Nordlinger B, Vaillant JC, Guiguet M, et al. 1994. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Française de Chirurgie. J. Clin. Oncol. 12:1491-96
108. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. 1995. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 117:296-304
109. Adam R, Bismuth H, Castaing D, et al. 1997. Repeat hepatectomy for colorectal liver metastases. Ann. Surg. 225:51-60
110. Suzuki S, Sakaguchi T, Yokoi Y, et al. 2001. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 129:421-28